David A. Giljohann

Chief Executive Officer at Exicure Operating Co.

David A. Giljohann

David A. Giljohann

Chief Executive Officer at Exicure Operating Co.

Biography

Dr. Giljohann is our Chief Executive Officer and director. Dr. Giljohann has served as our CEO since November 2013 and has been on our board of directors since March 2014. From July 2012 to October 2013, Dr. Giljohann was our Chief Operating Officer. From 2011 until June 2012, Dr. Giljohann served as our principal scientist. Dr. Giljohann was our founding scientist in 2011. Prior to that, Dr. Giljohann was the founding scientist of AuraSense, LLC, our largest stockholder, in 2009.

Dr. Giljohann completed his Ph.D. in the laboratory of Dr. Chad A. Mirkin where he developed oligonucleotide-modified nanoparticles, including NanoFlare™ and Spherical Nucleic Acid (SNA™) technologies. Dr. Giljohann was named to the Endpoint News’ “Under 40s” biopharma executives list in 2018 and the Analytical Scientist’s “Top 40 Under 40 Power List” in 2014. Dr. Giljohann has also been recognized for his work with a Materials Research Society Gold Award, Baxter Innovation Award, Rappaport Award for Research Excellence, NSEC Outstanding Research Award, and as a finalist in the National Inventors Hall of Fame Collegiate Inventors Competition.

Dr. Giljohann received his B.A. in Biology and Ph.D. in Biochemistry from Northwestern University.

Overview
Career Highlights

Exicure Operating Co.
Exicure, Inc.

RelSci Relationships

390

Number of Boards

2

Birthday

1981

Age

39

Relationships
RelSci Relationships are individuals David A. Giljohann likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at Quanterix Corp.

Relationship likelihood: Strong

Former Chief Business Officer at NGM Biopharmaceuticals, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at Angion Biomedica Corp.

Relationship likelihood: Strong

Associate Professor of Urology at Northwestern University - Feinberg School of Medicine

Relationship likelihood: Strong

Co-Founder, Chairman at Exicure, Inc.

Relationship likelihood: Strong

Chief Financial Officer at Exicure Operating Co.

Relationship likelihood: Strong

Vice President, Head of Business Development at Exicure Operating Co.

Relationship likelihood: Strong

Chief Operating Officer at Exicure Operating Co.

Relationship likelihood: Strong

Chief Medical Officer at Amplyx Pharmaceuticals, Inc.

Relationship likelihood: Strong

Former Chief Scientific Officer & Co-Founder at InDex Pharmaceuticals Holding AB

Relationship likelihood: Strong

Paths to David A. Giljohann
Potential Connections via
Relationship Science
You
David A. Giljohann
Chief Executive Officer at Exicure Operating Co.
Career History
Chief Executive Officer
Current

Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL.

Chief Executive Officer
2011 - Current

Exicure, Inc. engages in the provision of clinical stage biotechnology company. It offers 3-dimensional, spherical nucleic acid architecture unlocks the potential of nucleic acid therapeutics. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL.

Principal Scientist
Prior
Transactions
Details Hidden

Exicure Operating Co. raised money in a private placement transaction

Details Hidden

Exicure Operating Co. raised money in a private placement transaction

Public Holdings
Restricted data only for RelSci Professional users.
Other Affiliations

David A. Giljohann is affiliated with Exicure Operating Co., Exicure, Inc., Aurasense LLC

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by David A. Giljohann. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of David A. Giljohann's profile does not indicate a business or promotional relationship of any kind between RelSci and David A. Giljohann.